Release Date: 10/02/14 10:14 Summary: Notice of compulsory acquisition Price Sensitive: Yes Download Document 335.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%